Table 2 Association of EGFR Expression with clinicopathologic features of Urothelial carcinoma
| Â | EFGR Expression n (%) | P-Value | |||
|---|---|---|---|---|---|
No Expression (n = 74) | Low EFGR Expression (n = 19) | High EFGR expression (n = 33) | Total (n = 126) | ||
Gender | |||||
 Male | 54(73) | 14(73.7) | 23(69.7) | 91(72.2) | 0.930 |
 Female | 20(27) | 5(26.3) | 10(30.3) | 35(27.8) | |
Age Groupa | |||||
 ≤ 25 years | 1(1.4) | 0(0) | 0(0) | 0(0) | 0.263 |
 26–50 years | 21(28.4) | 2(10.5) | 2(10.5) | 5(15.2) | |
 > 50 years | 52(70.3) | 17(89.5) | 17(89.5) | 28(84.8) | |
Specimen Type a | |||||
 Transurethral resection | 72(97.3) | 19(100) | 30(90.9) | 121(96) | 0.209 |
 Radical Cystectomy | 2(2.7) | 0(0) | 3(9.1) | 5(4) | |
Tumor Grade | |||||
 Low Grade | 48(64.9) | 9(47.4) | 8(24.2) | 65(51.6) | 0.000 |
 High Grade | 26(35.1) | 10(52.6) | 25(75.8) | 61(48.4) | |
Lamina Propria Invasion | |||||
 Present | 15(20.3) | 3(15.8) | 17(51.5) | 35(27.8) | 0.002 |
 Absent | 59(79.7) | 16(84.2) | 16(48.5) | 91(72.2) | |
Deep Muscle Invasion a | |||||
 Present | 9(12.2) | 1(5.3) | 12(36.4) | 22(17.5) | 0.012 |
 Absent | 38(51.4) | 12(63.2) | 9(27.3) | 59(46.8) | |
 Can’t Assessed | 27(36.5) | 6(31.6) | 12(36.4) | 45(35.7) | |
Recurrence (n = 58) a | |||||
 Yes | 15(40.5) | 0(0) | 10(66.7) | 25(43.1) | 0.017 |
 No | 22(59.5) | 6(100) | 5(33.3) | 33(56.9) | |
Survival Status (n = 58) a | |||||
 Alive | 32(86.5) | 6(100) | 11(73.3) | 49(84.5) | 0.398 |
 Expired | 5(13.5) | 0(0) | 4(26.7) | 9(15.5) | |